Sex and gender differences in the management of chronic kidney disease and hypertension

Mayne, Kaitlin J.; Sullivan, Michael; Lees, Jennifer S

doi:10.1038/s41371-023-00843-9

Cited by 6 publications

(3 citation statements)

References 30 publications

(40 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…By doing so, it ensures the delivery of equitable, patient-centric care that takes into account the unique experiences and needs of diverse patient populations. Implementing such strategies can significantly contribute to the elimination of systemic barriers and biases, promoting a more inclusive and equitable healthcare system for individuals with kidney diseases [ 10 ].…”

Section: Editorialmentioning

confidence: 99%

“…Diagnostic criteria and therapeutic interventions should be refined to reflect the variances in how diseases present, respond to treatment, and the range of comorbidities that frequently diverge between men, women, and particularly women of color [ 11 ]. For instance, the management of hypertension in women with CKD needs to be sensitive to reproductive health considerations, including pregnancy, and should factor in the physiological effects of hormonal fluctuations and menopause [ 4 , 10 ]. This approach should also be inclusive of racial and ethnic differences that may influence the prevalence, progression, and treatment efficacy of kidney diseases.…”

Section: Editorialmentioning

confidence: 99%

See 1 more Smart Citation

Advancing Healthcare Equity in Nephrology: Addressing Racial and Ethnic Disparities in Research Trials and Treatment Strategies

Mohammed,

Khurana,

Gulati

et al. 2024

Cureus

View full text Add to dashboard Cite

Within the healthcare sector, especially in the field of nephrology, the matter of gender and racial inequalities continues to be a critical concern that requires immediate focus. Women, particularly those of underrepresented racial groups, face significant challenges due to a lack of representation in research studies, leading to a deficit in knowledge about how kidney diseases affect them differently. These challenges are exacerbated by systemic biases in the healthcare system, which manifest in both gender and racial dimensions, hindering access to and the quality of care for kidney diseases. Addressing these complex disparities requires a recalibration of risk stratification models to include both gender- and race-specific factors and a transformation of healthcare policies to facilitate a more inclusive and sensitive approach. Essential to this transformation is the empowerment of women of all races to actively participate in their healthcare decisions and the strengthening of support systems to help them navigate the complexities of the healthcare environment. Furthermore, education programs must be designed to be culturally competent and address the unique needs and concerns of women across different racial backgrounds. Promoting a collaborative patient-provider relationship is crucial in fostering an environment where equity, dignity, and respect are at the forefront. The path to equitable nephrology care lies in a concerted, collective action from researchers, healthcare providers, policymakers, and patients, ensuring that every individual receives the highest standard of care, irrespective of gender or race.

show abstract

Section: Editorialmentioning

confidence: 99%

Section: Editorialmentioning

confidence: 99%

Advancing Healthcare Equity in Nephrology: Addressing Racial and Ethnic Disparities in Research Trials and Treatment Strategies

Mohammed,

Khurana,

Gulati

et al. 2024

Cureus

View full text Add to dashboard Cite

show abstract

“…On the other hand, arterial hypertension plays a signi cant role in the onset and worsening of CKD (11). The prevalence of hypertension increases as renal function deteriorates, affecting approximately 60-90% of individuals with CKD (12). Hypertension is the most common chronic disease in developed societies and claims about 7.1 million lives worldwide each year (7).…”

Section: Introductionmentioning

confidence: 99%

Prevalence of hypertension and diabetes mellitus in Peruvian patients with chronic kidney disease: a systematic review and meta-analysis

León-Figueroa,

Aguirre-Milachay,

Barboza

et al. 2023

Preprint

View full text Add to dashboard Cite

Background Chronic Kidney Disease (CKD) represents a major challenge for public health, with hypertension and diabetes being the main causes of its occurrence. Therefore, this study aims to determine the prevalence of hypertension and diabetes mellitus in Peruvian patients with CKD. Methods A systematic review and meta-analysis were performed. For this purpose, a systematic search was carried out in various databases, including PubMed, Scopus, Embase, Web of Science, ScienceDirect, Google Scholar, Virtual Health Library (VHL), and Scielo, until December 1, 2023. The search terms used were "chronic kidney disease" and "Peru". Study selection, quality assessment, and data extraction were performed independently by two authors. Study quality was assessed using the Joanna Briggs Institute Statistical Meta-Analysis Assessment and Review Instrument. To analyze data heterogeneity, the I2 statistical test was used. Statistical analysis was performed with R version 4.2.3. Results A total of 1425 studies were collected, of which 23 were included in the final meta-analysis. A total of 43321 patients with CKD were evaluated, of whom 52.22% were male and 47.78% were female. The combined prevalence of hypertension in Peruvian patients with CKD was 38% (95% CI: 30–46%; 41131 participants; 21 studies, I2 = 99%, p = 0), while the combined prevalence of diabetes mellitus in Peruvian patients with CKD was 33% (95% CI: 26-40%; 43321 participants; 23 studies, I2 = 99%, p = 0). Additionally, the combined prevalence of Peruvian men and women with CKD was 55% (95% CI: 52-57%; 43321 participants; 23 studies, I2 = 93%, p < 0.01) and 45% (95% CI: 43-48%; 43321 participants; 23 studies, I2 = 93%, p < 0.01), respectively. Conclusion In accordance with the study, the combined prevalence of hypertension and diabetes in Peruvian patients with CKD was 38% and 33%, respectively.

show abstract

Journal of Human Hypertension special issue on sex and gender differences in hypertension

Connelly

Delles

2023

J Hum Hypertens

View full text Add to dashboard Cite

Sex and gender differences in the management of chronic kidney disease and hypertension

Cited by 6 publications

References 30 publications

Advancing Healthcare Equity in Nephrology: Addressing Racial and Ethnic Disparities in Research Trials and Treatment Strategies

Advancing Healthcare Equity in Nephrology: Addressing Racial and Ethnic Disparities in Research Trials and Treatment Strategies

Prevalence of hypertension and diabetes mellitus in Peruvian patients with chronic kidney disease: a systematic review and meta-analysis

Journal of Human Hypertension special issue on sex and gender differences in hypertension

Contact Info

Product

Resources

About